article thumbnail

Milestone Alert: Biofrontera Inc. Places 100th RhodoLED XL Machine in U.S. Market

The Dermatology Digest

We were thoroughly impressed by the lamps robust yet elegant design, as well as its exceptional maneuverability and adjustability, which made it ideal for Photodynamic Therapy (PDT) treatments in our offices, Dr. Hoover explains in a news release. Market appeared first on The Dermatology Digest. Biofrontera Inc.

article thumbnail

Marketing For Therapists: Proven Ways To Grow Your Practice

American Esthetician Organization

Marketing is key for therapists who want to expand their small business. In this article, we’ll be exploring 7 proven marketing strategies that will help you increase your brand visibility and gain more clients. Are you a therapist looking for ways to grow your practice? Let’s get into it!

article thumbnail

PHysicians & the esthetician

Southeastern Esthetics Institute

Having a thorough understanding of the dermatology and plastic surgery procedures, in addition to all new and modern cosmetic procedures on the market, is critical in assisting your clients in answering questions. A complete system must be in place per office, for the role of every action within the practice.

article thumbnail

U.S. FDA Clears Avita Medical’s Cohealyx for Healing Full-thickness Wounds

The Dermatology Digest

The post-market clinical study will assess Cohealyxs performance in real-world settings, focusing on clinical efficacy and cost savings in the treatment of full-thickness wounds and burns. These parameters will be evaluated in a clinical study.

article thumbnail

The 30% Margin Rule on ROI

Southeastern Esthetics Institute

Esthetics practitioners must spend quality office time at least quarterly to dive into three categories within their spreadsheets: Vendors, Disposables, and Human Resources. The business has overhead to pay - specifically, equipment loans, lease payments, internet bills, marketing costs, and much more.

Esthetics 195
article thumbnail

U.S. FDA Approves Celltrion’s STELARA Biosimilar

The Dermatology Digest

. “The approval of STEQEYMA reflects Celltrion’s continued investment in providing treatment options to patients diagnosed with ulcerative colitis, Crohn’s disease, psoriasis, and psoriatic arthritis,” says Thomas Nusbickel, Chief Commercial Officer at Celltrion USA, in a news release. immunology market.”

article thumbnail

5 Ways to Boost Retail

Aesthetics Exposed

Instead of saving all the best deals for the end of the year, grab a calendar and see what other important holidays or events that you can incorporate into your marketing agenda. Teenagers may not be the top demographic when it comes to marketing spa services and product sales, but a successful business must be able to meet all demographics.

Sales 195